4.7 Article

Ginsenoside Rg3 Protects against Diabetic Cardiomyopathy and Promotes Adiponectin Signaling via Activation of PPAR-γ

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

The adiponectin signalling pathway - A therapeutic target for the cardiac complications of type 2 diabetes?

Abhipree Sharma et al.

Summary: Diabetes is associated with an increased risk of heart failure known as diabetic cardiomyopathy. Adiponectin, a cardioprotective adipokine, is downregulated in diabetes and obesity, leading to reduced cardioprotection. This review summarizes the evidence linking suppressed adiponectin signaling pathway to cardiac dysfunction in diabetes and discusses potential therapeutic approaches for diabetic cardiomyopathy.

PHARMACOLOGY & THERAPEUTICS (2022)

Article Cardiac & Cardiovascular Systems

Panax notoginseng Saponin Protects Against Diabetic Cardiomyopathy Through Lipid Metabolism Modulation

Chenyang Zhang et al.

Summary: This study found that Panax notoginseng saponin (PNS) can attenuate heart dysfunction in diabetic mice by reducing lipotoxicity, modulating oxidative stress, and improving mitochondrial function.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Article Immunology

Ginsenoside Rb1 Protects Against Diabetic Cardiomyopathy by Regulating the Adipocytokine Pathway

Chenyang Zhang et al.

Summary: In this study, it was found that ginsenoside Rb1 can lower lipid levels, reduce inflammation, and improve cardiac function in diabetic cardiomyopathy by modulating the adipocytokine pathway.

JOURNAL OF INFLAMMATION RESEARCH (2022)

Review Pharmacology & Pharmacy

Pharmacological properties, molecular mechanisms and therapeutic potential of ginsenoside Rg3 as an antioxidant and anti-inflammatory agent

Jing Wang et al.

Summary: Inflammation and oxidative stress are the causes of various diseases, while ginsenoside Rg3 possesses antioxidant and anti-inflammatory activities, making it a potential treatment for these diseases.

FRONTIERS IN PHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus

Kazufumi Nakamura et al.

Summary: There is a strong correlation between diabetes mellitus and heart failure, with diabetes serving as an independent risk factor for heart failure. The link between diabetes and heart failure is not only due to complications such as ischemic heart disease, but also metabolic disorders like glucose toxicity and lipotoxicity caused by insulin resistance.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Medicine, Legal

A 26-week 20(S)-ginsenoside Rg3 oral toxicity study in Beagle dogs

Yonglin Gao et al.

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)

Review Pharmacology & Pharmacy

Relationship Between Ginsenoside Rg3 and Metabolic Syndrome

Hyunji Lee et al.

FRONTIERS IN PHARMACOLOGY (2020)

Review Biochemistry & Molecular Biology

The Mitochondria: A Target of Polyphenols in the Treatment of Diabetic Cardiomyopathy

Humna Bhagani et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Cardiac & Cardiovascular Systems

Multiple Levels of PGC-1α Dysregulation in Heart Failure

Shin-ichi Oka et al.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)

Review Cardiac & Cardiovascular Systems

Diabetic cardiomyopathy - A comprehensive updated review

Ghulam Murtaza et al.

PROGRESS IN CARDIOVASCULAR DISEASES (2019)

Editorial Material Cardiac & Cardiovascular Systems

Diabetic Cardiomyopathy What Is It and Can It Be Fixed?

Wolfgang H. Dillmann

CIRCULATION RESEARCH (2019)

Review Biochemistry & Molecular Biology

Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications

Michele Longo et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Medicine, Research & Experimental

Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome

C. Ronald Kahn et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Review Endocrinology & Metabolism

Thiazolidinediones: the Forgotten Diabetes Medications

Harold E. Lebovitz

CURRENT DIABETES REPORTS (2019)

Review Integrative & Complementary Medicine

Ginsenoside Rg3 (Shenyi Capsule) Combined with Chemotherapy for Digestive System Cancer in China: A Meta-Analysis and Systematic Review

Linlin Pan et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)

Review Integrative & Complementary Medicine

Panax notoginseng for Inflammation-Related Chronic Diseases: A Review on the Modulations of Multiple Pathways

Yu Xu et al.

AMERICAN JOURNAL OF CHINESE MEDICINE (2018)

Review Biochemistry & Molecular Biology

PGC-1: The Energetic Regulator in Cardiac Metabolism

Wencheng Di et al.

CURRENT ISSUES IN MOLECULAR BIOLOGY (2018)

Article Biochemistry & Molecular Biology

Combination of Berberine with Resveratrol Improves the Lipid-Lowering Efficacy

Xiaofei Zhu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Biochemistry & Molecular Biology

Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction

Arunkumar E. Achari et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Endocrinology & Metabolism

Ginsenoside Rg3 ameliorated HFD-induced hepatic steatosis through downregulation of STAT5-PPARγ

Jin-Bong Lee et al.

JOURNAL OF ENDOCRINOLOGY (2017)

Review Biochemistry & Molecular Biology

Adiponectin and Cardiovascular Disease: Mechanisms and New Therapeutic Approaches

G. Siasos et al.

CURRENT MEDICINAL CHEMISTRY (2012)

Review Biochemistry & Molecular Biology

PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty

Janice V. Huang et al.

JOURNAL OF LIPID RESEARCH (2012)

Review Cardiac & Cardiovascular Systems

Beneficial effects of PPAR-γ ligands in ischemia-reperfusion injury, inflammation and shock

M Abdelrahman et al.

CARDIOVASCULAR RESEARCH (2005)